24 May 2013
Keywords: amarin, revenues, tumble, first, quarter, uk-based, specialty
Article | 09 June 2003
UK-based specialty drugmaker Amarin has reported a net loss of $3.7 million for the first quarter of 2003 compared with a profit ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.